Commonwealth Bank of Australia’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-25,816
| Closed | -$6.03M | – | 129 |
|
|
2019
Q2 | $6.03M | Buy |
25,816
+3,544
| +16% | +$828K | 0.06% | 203 |
|
|
2019
Q1 | $5.26M | Buy |
22,272
+4,168
| +23% | +$984K | 0.05% | 220 |
|
|
2018
Q4 | $5.44M | Buy |
18,104
+2,070
| +13% | +$622K | 0.06% | 198 |
|
|
2018
Q3 | $5.66M | Buy |
16,034
+607
| +4% | +$214K | 0.05% | 216 |
|
|
2018
Q2 | $4.47M | Sell |
15,427
-2,706
| -15% | -$785K | 0.04% | 235 |
|
|
2018
Q1 | $4.96M | Sell |
18,133
-3,000
| -14% | -$820K | 0.05% | 214 |
|
|
2017
Q4 | $6.72M | Sell |
21,133
-466
| -2% | -$148K | 0.07% | 198 |
|
|
2017
Q3 | $6.76M | Buy |
21,599
+2,023
| +10% | +$633K | 0.07% | 195 |
|
|
2017
Q2 | $5.31M | Buy |
19,576
+5,758
| +42% | +$1.56M | 0.05% | 215 |
|
|
2017
Q1 | $3.78M | Buy |
13,818
+4,111
| +42% | +$1.12M | 0.04% | 246 |
|
|
2016
Q4 | $2.75M | Buy |
9,707
+1,588
| +20% | +$450K | 0.03% | 291 |
|
|
2016
Q3 | $2.54M | Sell |
8,119
-100
| -1% | -$31.3K | 0.03% | 285 |
|
|
2016
Q2 | $1.99M | Buy |
8,219
+882
| +12% | +$213K | 0.02% | 325 |
|
|
2016
Q1 | $1.91M | Buy |
7,337
+886
| +14% | +$231K | 0.02% | 325 |
|
|
2015
Q4 | $1.98M | Buy |
6,451
+87
| +1% | +$26.6K | 0.03% | 320 |
|
|
2015
Q3 | $1.86M | Buy |
6,364
+11
| +0.2% | +$3.21K | 0.02% | 336 |
|
|
2015
Q2 | $2.57M | Sell |
6,353
-266
| -4% | -$107K | 0.03% | 251 |
|
|
2015
Q1 | $2.8M | Sell |
6,619
-400
| -6% | -$169K | 0.04% | 242 |
|
|
2014
Q4 | $2.38M | Sell |
7,019
-4,602
| -40% | -$1.56M | 0.03% | 254 |
|
|
2014
Q3 | $3.84M | Sell |
11,621
-400
| -3% | -$132K | 0.05% | 202 |
|
|
2014
Q2 | $3.79M | Sell |
12,021
-24,040
| -67% | -$7.58M | 0.05% | 206 |
|
|
2014
Q1 | $11M | Buy |
36,061
+4,097
| +13% | +$1.25M | 0.07% | 274 |
|
|
2013
Q4 | $8.94M | Buy |
31,964
+6,582
| +26% | +$1.84M | 0.06% | 296 |
|
|
2013
Q3 | $6.11M | Sell |
25,382
-700
| -3% | -$169K | 0.04% | 351 |
|
|
2013
Q2 | $5.61M | Buy |
+26,082
| New | +$5.61M | 0.04% | 350 |
|